Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Hee Lee

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Cancer Medicine|June 2, 2023
Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06Byeong Seok Sohn, Jeongeun Kim, Miso Kim, et al.
BMC Cancer|December 30, 2024
Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancerJeeyeon Lee, Byeongju Kang, Jin Hyang Jung, et al.
Clinical Lung Cancer|March 20, 2016
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung CancerIn-Ho Kim, In Hee Lee, Ji Eun Lee, et al.
Annals of Surgical Oncology|October 4, 2016
Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung AdenocarcinomaIn-Ho Kim, In Hee Lee, Ji Eun Lee, et al.
Oncotarget|February 22, 2018
Quantitative radiomic profiling of glioblastoma represents transcriptomic expressionDoo-Sik Kong, Junhyung Kim, Gyuha Ryu, et al.
Cancers|March 28, 2026
Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before SurgeryJeeyeon Lee, Byeongju Kang, Joon Suk Moon, et al.
The Korean Journal of Internal Medicine|October 11, 2018
Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapyIn Hee Lee, Byung Woog Kang, Jong Gwang Kim, et al.
Anticancer Research|May 2, 2018
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination ChemotherapyGi Yong Hwang, Dong Won Baek, Hee Jeong Cho, et al.
Annals of Hematology|August 18, 2016
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromesYoo Jin Lee, Sung Woo Park, In Hee Lee, et al.
Nature Genetics|June 9, 2016
Clonal evolution of glioblastoma under therapyJiguang Wang, Emanuela Cazzato, Erik Ladewig, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Cancer Medicine|June 2, 2023
Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06Byeong Seok Sohn, Jeongeun Kim, Miso Kim, et al.
BMC Cancer|December 30, 2024
Feasibility of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for targeting suspicious axillary lymph nodes in patients with breast cancerJeeyeon Lee, Byeongju Kang, Jin Hyang Jung, et al.
Clinical Lung Cancer|March 20, 2016
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung CancerIn-Ho Kim, In Hee Lee, Ji Eun Lee, et al.
Annals of Surgical Oncology|October 4, 2016
Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung AdenocarcinomaIn-Ho Kim, In Hee Lee, Ji Eun Lee, et al.
Oncotarget|February 22, 2018
Quantitative radiomic profiling of glioblastoma represents transcriptomic expressionDoo-Sik Kong, Junhyung Kim, Gyuha Ryu, et al.
Cancers|March 28, 2026
Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before SurgeryJeeyeon Lee, Byeongju Kang, Joon Suk Moon, et al.
The Korean Journal of Internal Medicine|October 11, 2018
Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapyIn Hee Lee, Byung Woog Kang, Jong Gwang Kim, et al.
Anticancer Research|May 2, 2018
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination ChemotherapyGi Yong Hwang, Dong Won Baek, Hee Jeong Cho, et al.
Annals of Hematology|August 18, 2016
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromesYoo Jin Lee, Sung Woo Park, In Hee Lee, et al.
Nature Genetics|June 9, 2016
Clonal evolution of glioblastoma under therapyJiguang Wang, Emanuela Cazzato, Erik Ladewig, et al.
Pageof 20